|
FY2025
12 months to Jan 30, 2026
|
FY2024
12 months to Jan 31, 2025
|
FY2023
12 months to Feb 2, 2024
|
FY2022
12 months to Jan 27, 2023
|
FY2021
12 months to Jan 28, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of sales (excluding depreciation and amortization) | |||||
| Gross profit | |||||
| Selling and administrative | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Other operating expense, net | |||||
| Total costs and expenses | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Other (income) expense, net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| NET INCOME (LOSS) | |||||
| NET EARNINGS (LOSS) PER COMMON SHARE ATTRIBUTABLE TO STOCKHOLDERS | |||||
| Basic: | |||||
| Diluted: | |||||
| Basic weighted average common shares outstanding | |||||
| Diluted weighted average common shares outstanding |
Loading...
